Literature DB >> 25668830

[Epidemiology of and risk factors for bladder cancer and for urothelial tumors].

Legrand Guillaume, Laurent Guy.   

Abstract

Bladder cancer is the 5th most commonly diagnosed cancer in France, and most of cases occur in men and patients aged more than 65 years. The incidence and mortality are declining except in women in whom the incidence is increasing in recent years. Urothelial tumors of the upper urinary tract are less common but have similar aetiology to the bladder tumours. The recurrent aspect of superficial tumors and the morbidity of invasive tumors are an economic burden in the Western health systems. The two main risk factors for urothelial tumors are tobacco smoking and occupational exposure to chemicals carcinogens such as polycyclic aromatic hydrocarbons, nitrosamines, aromatic amines and arsenic. Other risk factors include urinary schistosomiasis, pelvic radiation therapy, the use of cyclophosphamide and probably diet and lifestyle factors. Prevention of bladder tumors is based on the control of these risk factors and individual screening in high-risk patients. Recognition as an occupational disease is an important part of the social management of patient, which is today inadequately performed.

Entities:  

Mesh:

Year:  2014        PMID: 25668830

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  8 in total

1.  Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy.

Authors:  Hyeong Dong Yuk; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Transl Androl Urol       Date:  2020-06

2.  TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.

Authors:  Sheng-Lin Gao; Chui-Ze Kong; Zhe Zhang; Ze-Liang Li; Jian-Bin Bi; Xian-Kui Liu
Journal:  Oncol Rep       Date:  2017-08-07       Impact factor: 3.906

3.  TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling.

Authors:  Wei Chen; Kewang Luo; Zhiyi Ke; Bin Kuai; Shiyang He; Wei Jiang; Weiren Huang; Zhiming Cai
Journal:  J Cancer       Date:  2017-07-03       Impact factor: 4.207

4.  Urine cytology screening of French workers exposed to occupational urinary tract carcinogens: a prospective cohort study over a 20-year period.

Authors:  Frederic Dutheil; Lucile Rouanet; Aurélien Mulliez; Geraldine Naughton; Luc Fontana; Michel Druet-Cabanac; Farès Moustafa; Alain Chamoux
Journal:  BMJ Open       Date:  2017-09-21       Impact factor: 2.692

5.  CMTM8 inhibits the carcinogenesis and progression of bladder cancer.

Authors:  Denghui Gao; Hao Hu; Ying Wang; Weidong Yu; Jianhua Zhou; Xiaofeng Wang; Weiping Wang; Chunyan Zhou; Kexin Xu
Journal:  Oncol Rep       Date:  2015-12       Impact factor: 3.906

6.  Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis.

Authors:  Lushun Yuan; Bo Shu; Liang Chen; Kaiyu Qian; Yongzhi Wang; Guofeng Qian; Yuan Zhu; Xinyue Cao; Conghua Xie; Yu Xiao; Xinghuan Wang
Journal:  Oncotarget       Date:  2017-07-28

7.  Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.

Authors:  Rossana Critelli; Francesca Fasanelli; Marco Oderda; Silvia Polidoro; Manuela Bianca Assumma; Clara Viberti; Mirko Preto; Paolo Gontero; Giuseppina Cucchiarale; Irene Lurkin; Ellen C Zwarthoff; Paolo Vineis; Carlotta Sacerdote; Giuseppe Matullo; Alessio Naccarati
Journal:  Oncotarget       Date:  2016-10-11

8.  Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.

Authors:  Mingkun Chen; Rongpei Wu; Gang Li; Cundong Liu; Lei Tan; Kanghua Xiao; Yunlin Ye; Zike Qin
Journal:  J Exp Clin Cancer Res       Date:  2018-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.